
When factoring in what is now known about breast cancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone-receptor positive disease, according to research.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/VzsKEmiXK5I/140904103336.htm